Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ASPERGILLUS TERREUS

QBN8K7055X

Status:

US Approved Allergenic Extract

Source:

BLA103888

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b528ac31-0e71-4373-87ff-04de1cdc109d

First approved in 1965

Source:

BLA103753

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f15c12a-8df0-41de-9d59-7de47e5e89ca

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

ASPERGILLUS TERREUS

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1